FDA NDC Directory · JSON-LD · Markdown

Augtyro

NDC 0003-4040 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namerepotrectinib
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryNew Drug Application (innovator) · App NDA218213
Dosage form / routeCAPSULE · ORAL
Active ingredientsREPOTRECTINIB (40 mg/1)
Marketing started20231205
Package count2

External sources

Source: openFDA. Public-domain (CC0).